The F-18-fluorodeoxylucose (FDG) positron emission tomography (PET) is the gold standard imaging modality in the staging of lymphoma. The superscan appearance in the FDG PET/computerized tomography (CT) imaging might be because of benign diseases or malignant infiltrations. This case report presents lymphomatous blastic infiltration as a cause of superscan appearance in F-18-FDG PET/CT.
15 April 2026 in Indian Journal of Surgical Oncology
Aim: The ratio and results of the hypermetabolic lesions of the pancreas in lung carcinoma patients in FDG PET-CT which is rare, wasn’t sufficiently evaluated previously in the literature. The aim of this study was to determine these lesions’ pathologic correlations. Materials and Methods: The F-18 FDG PET/CT images of the 516 patients with Lung Carcinoma was evaluated retrospectively by an Experienced Nuclear Medicine Physician and correlation of Pathology results were analyzed. Results: The ratio of the pancreatic hypermetabolic lesions were 7% (36 patients). Pathology results revealed small cell lung carcinoma metastasis in 23, adenocarcinoma in 8, squamous cell carcinoma in 1 and atypical carcinoid tumor in 1 and other pathology types in rest of the patients in primary Lung Carcinoma. Five of the pancreatic lesions pathology results could be obtained and three were small cell lung carcinoma, one of them was adenocarcinoma and the squamous cell carcinoma in other one. Conclusion: The hypermetabolic pancreatic lesions in Lung Carcinoma patients in F-18 FDG PET/CT should be evaluated and considered carefully. Since unexpected pathology results could be achieved.
30 September 2025 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Amaç: Bu çalışma, meme kanseri tedavisinde tamoksifen (TMX) kullanan kadınlarda endometrial hiperplastik değişiklikler, tamoksifen kullanım süresi ve anormal uterin kanama (AUB) arasındaki ilişkiyi araştırmayı amaçlamıştır. Gereç ve Yöntemler: Ocak 2019 ile Şubat 2024 arasında cerrahi işlemler geçiren 178 meme kanseri hastasının patoloji sonuçları üzerine retrospektif bir inceleme yapıldı. Hastalar iki gruba ayrıldı: TMX tedavisi alanlar (n=104) ve almayanlar (n=78). Endometrial patoloji sonuçları, yaş, parite, menopoz durumu, BMI, ultrasonografi bulguları ve AUB semptomları değerlendirildi. Bulgular: Tüm hastaların ortalama yaşı 49,7 yıldı. TMX grubunun ortalama yaşı ve BKI, non-TMX grubuna kıyasla anlamlı derecede daha düşüktü (p